Literature DB >> 29948268

Role of asthma and intolerance to acetylsalicylic acid on the redox profile in nasal polyp tissue.

Diego Antonio Mena Canata1,2, Fernanda Schäfer Hackenhaar1,2, Tiago Boeira Salomon1,2, Ártur Krumberg Schüller1,2, Guilherme Luis Franche da Silva3, Cassiano Teixeira4, Mara Silveira Benfato5,6.   

Abstract

PURPOSE: Nasal polyposis is a chronic inflammatory disease of the mucosa of the nasal cavity and paranasal sinuses. The etiology of nasal polyposis is unclear; however, it may be associated with asthma and intolerance to acetylsalicylic acid, possibly altering the redox profile. The study intends to compare the redox profile in polyps surgically removed from three clinical groups of patients with nasal polyposis who were divided according to the presence of asthma and intolerance to acetylsalicylic acid.
METHODS: Patients were divided into three groups: nasal polyposis only (n = 30); nasal polyposis and asthma (n = 19); and nasal polyposis, asthma and intolerance to acetylsalicylic acid (n = 10). The following redox evaluations were performed: enzymatic antioxidant activity of superoxide dismutase, glutathione peroxidase, hydrogen peroxide consumption and glutathione S-transferase; non-enzymatic antioxidant levels of vitamin C, vitamin E and glutathione; levels of the oxidative damage biomarkers carbonyl groups (measuring protein damage) and malondialdehyde (measuring lipid peroxidation); and nitrite and nitrate levels.
RESULTS: Compared with the polyposis only group, hydrogen peroxide consumption, glutathione S-transferase, vitamin E and malondialdehyde were lower in the asthma group. Total glutathione (0.12 ± 0.01 vs. 33.34 ± 10.48 µmol/mg) and nitrite and nitrate (0.06 ± 0.01 vs. 15.95 ± 1.38 nmol/mg) levels were higher in the nasal polyposis, asthma and intolerance to acetylsalicylic acid group.
CONCLUSIONS: In patients with nasal polyposis, asthma may alter the redox profile associated with the hydrogen peroxide and lipid damage pathways, whereas asthma and intolerance to acetylsalicylic acid increase nitrite and nitrate and total glutathione levels.

Entities:  

Keywords:  Antioxidant; Nasal polyposis; Nitric oxide; Oxidative damage; Oxidative stress; Redox profile

Mesh:

Substances:

Year:  2018        PMID: 29948268     DOI: 10.1007/s00405-018-5034-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

Review 1.  Oxidants and human disease: some new concepts.

Authors:  B Halliwell
Journal:  FASEB J       Date:  1987-11       Impact factor: 5.191

2.  [IV Brazilian Guidelines for the management of asthma].

Authors: 
Journal:  J Bras Pneumol       Date:  2006       Impact factor: 2.624

Review 3.  Intestinal lipid absorption and lipoprotein formation.

Authors:  M Mahmood Hussain
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

4.  Questionnaire-Based Anti-Inflammatory Diet Index as a Predictor of Low-Grade Systemic Inflammation.

Authors:  Joanna Kaluza; Holly Harris; Håkan Melhus; Karl Michaëlsson; Alicja Wolk
Journal:  Antioxid Redox Signal       Date:  2017-10-12       Impact factor: 8.401

5.  Lipid peroxidation and some antioxidant enzymes in nasal polyp tissue.

Authors:  Seyithan Taysi; Celil Uslu; Adnan Yilmaz; Bulent Aktan; Enver Altas
Journal:  Cell Biochem Funct       Date:  2006 Sep-Oct       Impact factor: 3.685

Review 6.  Biologics and biomarkers for asthma, urticaria, and nasal polyposis.

Authors:  Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2017-05       Impact factor: 10.793

7.  Olfactory dysfunction in nasal polyposis: correlation with computed tomography findings.

Authors:  Iordanis Konstantinidis; Stefanos Triaridis; Athanasia Printza; Victor Vital; Eleftherios Ferekidis; Jannis Constantinidis
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2007-04-04       Impact factor: 1.538

8.  Selenium, glutathione peroxidase and superoxide dismutase in maltese asthmatic patients: effect of glucocorticoid administration.

Authors:  A G Fenech; R Ellul-Micallef
Journal:  Pulm Pharmacol Ther       Date:  1998       Impact factor: 3.410

9.  Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy.

Authors:  S M Ragab; V J Lund; H A Saleh; G Scadding
Journal:  Allergy       Date:  2006-06       Impact factor: 13.146

10.  Genetic polymorphism of antioxidant enzymes in eosinophilic and non-eosinophilic nasal polyposis.

Authors:  Abdulvahap Akyigit; Erol Keles; Ebru Onalan Etem; Ibrahim Ozercan; Hatice Akyol; Oner Sakallioglu; Turgut Karlidag; Cahit Polat; Irfan Kaygusuz; Sinasi Yalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-11       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.